These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 22701727)
41. Conformational diversity of wild-type Tau fibrils specified by templated conformation change. Frost B; Ollesch J; Wille H; Diamond MI J Biol Chem; 2009 Feb; 284(6):3546-51. PubMed ID: 19010781 [TBL] [Abstract][Full Text] [Related]
42. Molecular structures of amyloid and prion fibrils: consensus versus controversy. Tycko R; Wickner RB Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335 [TBL] [Abstract][Full Text] [Related]
43. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations. Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046 [TBL] [Abstract][Full Text] [Related]
44. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation. Moore CL; Huang MH; Robbennolt SA; Voss KR; Combs B; Gamblin TC; Goux WJ Biochemistry; 2011 Dec; 50(50):10876-86. PubMed ID: 22085312 [TBL] [Abstract][Full Text] [Related]
45. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display. Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027 [TBL] [Abstract][Full Text] [Related]
46. Initiation and synergistic fibrillization of tau and alpha-synuclein. Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745 [TBL] [Abstract][Full Text] [Related]
47. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties. Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699 [TBL] [Abstract][Full Text] [Related]
48. Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS, and TDP-43 fibrils: A molecular dynamics study. Kochen NN; Seaney D; Vasandani V; Murray M; Braun AR; Sachs JN Proteins; 2024 Jul; 92(7):854-864. PubMed ID: 38458997 [TBL] [Abstract][Full Text] [Related]
49. Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322. Mo ZY; Zhu YZ; Zhu HL; Fan JB; Chen J; Liang Y J Biol Chem; 2009 Dec; 284(50):34648-57. PubMed ID: 19826005 [TBL] [Abstract][Full Text] [Related]
50. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation. Baughman HER; Clouser AF; Klevit RE; Nath A J Biol Chem; 2018 Feb; 293(8):2687-2700. PubMed ID: 29298892 [TBL] [Abstract][Full Text] [Related]
51. Unravelling the Novel Effects of Three Volatile Compounds in Preventing Fibril Formation of Disease Related Tau and α-Synuclein Proteins- Towards Identifying Candidate Aromatic Substances for Treating Neurodegenerative Diseases. Moeini Z; Seraj Z; Zohoorian Abootorabi T; Ashrafi-Kooshk M; Riazi G; Saboury AA; Seyedarabi A Front Pharmacol; 2022; 13():793727. PubMed ID: 35392564 [No Abstract] [Full Text] [Related]
52. Network of hotspot interactions cluster tau amyloid folds. Mullapudi V; Vaquer-Alicea J; Bommareddy V; Vega AR; Ryder BD; White CL; Diamond MI; Joachimiak LA Nat Commun; 2023 Feb; 14(1):895. PubMed ID: 36797278 [TBL] [Abstract][Full Text] [Related]
53. Conformational changes during amyloid fibril formation of pancreatic thiol proteinase inhibitor: effect of copper and zinc. Priyadarshini M; Bano B Mol Biol Rep; 2012 Mar; 39(3):2945-55. PubMed ID: 21789485 [TBL] [Abstract][Full Text] [Related]
54. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau. Bhasne K; Sebastian S; Jain N; Mukhopadhyay S J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492 [TBL] [Abstract][Full Text] [Related]
55. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854 [TBL] [Abstract][Full Text] [Related]
56. Disease-associated patterns of acetylation stabilize tau fibril formation. Li L; Nguyen BA; Mullapudi V; Li Y; Saelices L; Joachimiak LA Structure; 2023 Sep; 31(9):1025-1037.e4. PubMed ID: 37348495 [TBL] [Abstract][Full Text] [Related]
57. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death. Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444 [TBL] [Abstract][Full Text] [Related]
59. Methods for Structural Analysis of Amyloid Fibrils in Misfolding Diseases. Vadukul DM; Al-Hilaly YK; Serpell LC Methods Mol Biol; 2019; 1873():109-122. PubMed ID: 30341606 [TBL] [Abstract][Full Text] [Related]
60. The effect of limited proteolysis by different proteases on the formation of whey protein fibrils. Gao YZ; Xu HH; Ju TT; Zhao XH J Dairy Sci; 2013; 96(12):7383-92. PubMed ID: 24119812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]